<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE Insulin has mitogenic effects, although <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> may be a risk factor for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>It remains uncertain whether use of insulin increases <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk because of its effect on cell growth and proliferation or decreases <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk because of its <z:chebi fb="105" ids="17234">glucose</z:chebi>-lowering effect </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS A 1:2-matched new insulin user cohort on age (+/-3 years), smoking status, and likelihood of initiating insulin therapy (+/-0.05) was selected from a cohort of 4,623 Chinese patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, free of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, and naive to insulin at enrollment </plain></SENT>
<SENT sid="3" pm="."><plain>Stratified Cox regression analysis on the matched pairs was used to obtain hazard ratios (HRs) of insulin therapy and A1C for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk </plain></SENT>
<SENT sid="4" pm="."><plain>A structured adjustment scheme was used to adjust for covariates </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS Of 973 new insulin users, 971 had matched nonusers (n = 1935) </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incidence in insulin nonusers was much higher than that in insulin users (49.2 vs. 10.2, per 1,000 person-years, P &lt; 0.0001) </plain></SENT>
<SENT sid="7" pm="."><plain>After further adjustment for <z:hpo ids='HP_0000001'>all</z:hpo> other covariates with a P value less than 0.3 and nonlinear associations with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, A1C was associated with an increased <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk (HR per percentage 1.26, 95% CI 1.03-1.55), whereas use of insulin was associated with a decreased <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk (HR of insulin users vs. nonusers: 0.17, 0.09-0.32) </plain></SENT>
<SENT sid="8" pm="."><plain>Consistent results were found in analyses including <z:hpo ids='HP_0000001'>all</z:hpo> 973 insulin users and 3,650 nonusers </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS In Chinese patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> predicts <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, whereas insulin usage was associated with a reduced <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk </plain></SENT>
</text></document>